Literature DB >> 70647

Possible effects of growth hormone on development of acute lymphoblastic leukaemia.

P C Rogers, D Komp, A Rogol, H Sabio.   

Abstract

Growth hormone (G.H.) or a G.H.-dependent somatomedin may be involved in the process of acute lymphoblastic leukaemia (A.L.L.). Growth hormone has a trophic effect on lymphoid tissue and also specific receptors on lymphocytes, most probably T cells. Hypophycess. Resting concentrations of G.H. and somatomedin activity are raised in some children with A.L.L. and may be reduced after remission is achieved. It is suggested that control of G.H. and/or somatomedin concentrations may be necessary for adequate treatment of some cases of A.L.L. in children.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70647     DOI: 10.1016/s0140-6736(77)90613-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Authors:  Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson
Journal:  J Clin Endocrinol Metab       Date:  2015-04-03       Impact factor: 5.958

2.  Endocrine regulation of the immune system.

Authors:  W Kiess; B H Belohradsky
Journal:  Klin Wochenschr       Date:  1986-01-02

3.  Modulation of lymphoproliferation by human growth hormone.

Authors:  W Kiess; H Holtmann; O Butenandt; R Eife
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

4.  Height and lymphoblastic leukaemia.

Authors:  J Broomhall; R May; J S Lilleyman; R D Milner
Journal:  Arch Dis Child       Date:  1983-04       Impact factor: 3.791

5.  Wilms tumour in a patient with growth hormone replacement therapy.

Authors:  T Momoi; C Yamanaka; T Yorifuji; H Sasaki; M Kaji; Y Akiyama; Y Inomata; K Tanaka; H Mikawa
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

Review 6.  Growth hormone therapy and leukaemia.

Authors:  N Stahnke; H J Zeisel
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

7.  Lack of mitogenic effects of growth hormone on human leukemic lymphoblasts.

Authors:  J Blatt; S Wenger; S Stitely; P A Lee
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

8.  Obstacles to the prescribing of growth hormone in children with chronic kidney disease.

Authors:  Larry A Greenbaum; Guillermo Hidalgo; Deepa Chand; Myra Chiang; Katherine Dell; Theresa Kump; Lena Peschansky; Holly K Smith; Mary Boyle; Michelle Kopf; Lisa C Metz; Margaret Kamel; John D Mahan
Journal:  Pediatr Nephrol       Date:  2008-06-05       Impact factor: 3.714

9.  Can GH induce chromosome breaks or microsatellite instability in GH-deficient children?

Authors:  C Olivieri; C Danesino; S Scappaticci; M Bozzola
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

10.  Height at diagnosis of malignancies.

Authors:  C H Pui; R K Dodge; S L George; A A Green
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.